Evidence map›Paper›PMID 31239862›Full record

ReviewEvidence-based complementary and alternative medicine : eCAM2019

The Effects of Various Essential Oils on Epilepsy and Acute Seizure: A Systematic Review.

Tyler A Bahr, Damian Rodriguez, Cody Beaumont, Kathryn Allred

Open access · hybridAbstract readReview
In one paragraph

Review in Evidence-based complementary and alternative medicine : eCAM, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Therapeutic Efficacy ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  8. Review
  9. Lavender Plant: Farming and Health Benefits.Current molecular medicine · 2024
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Essential Oil fromMolecules (Basel, Switzerland) · 2023
    Review
  15. Pharmaceutical biology · 2022
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Oxidative medicine and cellular longevity · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tyler A BahrdōTERRA International, LLC, 389 S. 1300 W, Pleasant Grove, UT 84062, USA.ORCID 0000-0002-3482-0547
Damian RodriguezdōTERRA International, LLC, 389 S. 1300 W, Pleasant Grove, UT 84062, USA.
Cody BeaumontdōTERRA International, LLC, 389 S. 1300 W, Pleasant Grove, UT 84062, USA.
Kathryn AllreddōTERRA International, LLC, 389 S. 1300 W, Pleasant Grove, UT 84062, USA.ORCID 0000-0001-5464-5339
The University of Texas Health Science Center at San Antonio · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many essential oils (EOs) have anticonvulsant activity and might benefit people with epilepsy. Lemongrass, lavender, clove, dill, and other EOs containing constituents such as asarone, carvone, citral, eugenol, or linalool are good candidates for evaluation as antiepileptic drugs. On the other hand, some EOs have convulsant effects and may trigger seizures in both epileptic and healthy individuals. Internal use of EOs like sage, hyssop, rosemary, camphor, pennyroyal, eucalyptus, cedar, thuja, and fennel can cause epileptic seizures because they contain thujone, 1,8-cineole, camphor, or pinocamphone, which have been identified as convulsive agents. While more research is needed to confirm their mechanisms of action, it appears that the convulsant or anticonvulsant properties of essential oils are largely due to (1) their ability to modulate the GABAergic system of neurotransmission and (2) their capacity to alter ionic currents through ion channels. This review presents a systematic analysis of the current research on EOs and epilepsy, including human case studies, animal models, and

Identifiers

PMID31239862
PMCPMC6556313
OpenAlexW2945352109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.